newsfilter
← Latest News
PR Newswire·

Leap Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results

CAMBRIDGE, Mass., March 24, 2023 /PRNewswire/ -- Leap Therapeutics, Inc. (NASDAQ:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported financial results for the